Denmark, Norway and Iceland today joined other EU countries in suspending use of the AstraZeneca-Oxford vaccine following reports of blood clots and the death of a 60-year-old woman in Denmark.
Government data show that, compared with the Pfizer vaccine, there have been 43% more reports of injuries related to the Oxford-AstraZeneca vaccine in the UK, including 77% more adverse events and 25% more deaths — but no red flags from UK regulators.
